These results show that ADAMTS9‐AS2 is overexpressed in both MDAMB‐231 and MCF7 cells following DNMT1 silencing indicating methylation‐mediated suppression of ADAMTS9‐AS2 in breast cancer cells. This evidence concerns the gene ADAMTS9 and breast carcinoma.